GOLDMAN SACHS GROUP INC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 54 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$64,000
-40.2%
122,975
-13.5%
0.00%
Q2 2020$107,000
+11.5%
142,215
+52.4%
0.00%
Q1 2020$96,000
-23.2%
93,292
+15.6%
0.00%
Q4 2019$125,000
+14.7%
80,703
+32.9%
0.00%
Q3 2019$109,000
+65.2%
60,702
+51.3%
0.00%
Q2 2019$66,000
-88.2%
40,120
-87.2%
0.00%
Q1 2019$560,000
+608.9%
312,769
+651.8%
0.00%
Q4 2018$79,000
-33.6%
41,600
+24.8%
0.00%
Q3 2018$119,000
+35.2%
33,336
-21.6%
0.00%
Q2 2018$88,00042,5120.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders